O
Olivier Elemento
Researcher at Cornell University
Publications - 596
Citations - 38936
Olivier Elemento is an academic researcher from Cornell University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 82, co-authored 471 publications receiving 27739 citations. Previous affiliations of Olivier Elemento include Princeton University & Max Planck Society.
Papers
More filters
Journal ArticleDOI
Towards a better cancer precision medicine: systems biology meets immunotherapy.
TL;DR: It is argued that systems-level approaches are needed to help understand the concerted impact of tumor-specific and immune-specific molecular features on clinical outcomes, predict responders and unravel the complexity of tumor ecosystems.
Journal ArticleDOI
Correction: Unmasking Activation of the Zygotic Genome Using Chromosomal Deletions in the Drosophila Embryo
TL;DR: This work shows that the expression profile for at least one third of zygotically active genes is coupled to the concomitant degradation of the corresponding maternal mRNAs, and proposes that this regulatory mode links morphogen gradients with temporal regulation during the maternal-to-zygotic transition.
Journal ArticleDOI
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
Iris E Ertl,Ursula Lemberger,Dafina Ilijazi,Melanie R. Hassler,Andreas Bruchbacher,Robert Brettner,Hannah Kronabitter,M. Gutmann,Petra Vician,Gerhard Zeitler,Anna Koren,Charles-Hugues Lardeau,Thomas Mohr,Andrea Haitel,Eva Comperat,André Oszwald,Gabriel Wasinger,Thomas Clozel,Olivier Elemento,Stefan Kubicek,Walter Berger,Shahrokh F. Shariat +21 more
TL;DR: In this paper , the authors used commercially available cell lines for the identification of novel drugs for the treatment of bladder cancer and confirmed the effects of one of these drugs, clofarabine, in patient derived cell lines and two different mouse models, thereby demonstrating the potential clinical relevance of this substance in bladder cancer treatment.
Posted ContentDOI
Single-cell analysis of the muscle stem cell hierarchy identifies heterotypic communication signals involved in skeletal muscle regeneration
Andrea J. De Micheli,Paula Fraczek,Sharon Soueid-Baumgarten,Hiranmayi Ravichandran,Iwijn De Vlaminck,Olivier Elemento,Benjamin D. Cosgrove +6 more
TL;DR: In this article, a hierarchical map of myogenic cell populations and identifying stage-specific regulatory programs that govern their contributions to muscle regeneration is provided. But, a unified organization of muscle stem and progenitor cells and their subpopulations remains unresolved.
Journal ArticleDOI
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer.
Weisi Liu,Kevin P. Newhall,Francesca Khani,LaMont J. Barlow,Duy Nguyen,Lilly Gu,Kenneth Eng,Bhavneet Bhinder,Manik Uppal,Charlotte Récapet,Andrea Sboner,Susan R. Ross,Olivier Elemento,Linda Chelico,Bishoy Faltas +14 more
TL;DR: In this article , the mutagenic signatures attributed to APOBEC3 cytidine deaminases are pervasive in human cancers and the authors showed that transgenic expression of human APEC3G promotes mutagenesis, genomic instability, and kataegis, leading to shorter survival in a murine bladder cancer model.